This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 1 EPO patent. Top assignees: Arch Biopartners, Inc., Arch Cancer Therapeutics, Inc.. Active years: 2013-2026.
Company Filing History:
Years Active: 2013-2026
Title: Innovations by Donna Lorraine Senger
Introduction
Donna Lorraine Senger is a prominent inventor based in Calgary, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the area of reducing inflammation and treating various medical conditions. With a total of 8 patents to her name, Senger's work has the potential to impact many lives.
Latest Patents
Among her latest patents are the "DPEP-1 binding compositions and methods of use" and "DPEP-1 binding agents and methods of use." These pharmaceutical compositions are designed to reduce inflammation in subjects, block leukocyte recruitment, inhibit tumor metastasis, treat sepsis, and prevent or reduce acute kidney injury. Her innovative approaches in these areas highlight her commitment to advancing medical science.
Career Highlights
Senger has worked with notable companies such as Arch Cancer Therapeutics, Inc. and Arch Biopartners, Inc. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to the advancement of therapeutic solutions in the medical field.
Collaborations
Some of her coworkers include Stephen Mark Robbins and Jennifer Joy Rahn. Their collaborative efforts have likely played a role in the success of her innovative projects.
Conclusion
Donna Lorraine Senger's contributions to pharmaceutical innovations demonstrate her dedication to improving health outcomes. Her patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions.